Patients with poor clopidogrel response
| Baseline clopidogrel 75 mg/d | Clopidogrel 150 mg/d | Reduction | |
|---|---|---|---|
| PRI | 83±14 % | 60±33 % | 28 % (p < 0.00001) |
| ADPmax | 61±24 % | 54±33 % | (p > 0.05) |
Reduction in platelet reactivity after doubling clopidogrel dose
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.